Recently, our group identified extracellular S1P as one of the soluble factors that provides MM with supportive signals from the microenvironment by increasing Growth Factor Independence 1 (GFI1) transcription factor levels. The gene discussed is GFI1; the disease is Miyoshi myopathy.